Nimbic
Back to search
LFCR

LFCR

HealthcareDrug Manufacturers-Specialty & Generic

$4.02

Last close

Market Cap

$0.2B

Employees

406

Type

Public

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Leads

AI-generated opportunities from financial data

LFCR (LFCR) — Financial Highlights & AI Enterprise Leads | Nimbic